337 Intratumoral immune therapy for recurrent breast cancer with polyICLC, and tremelimumab combined with systemic durvalumab

التفاصيل البيبلوغرافية
العنوان: 337 Intratumoral immune therapy for recurrent breast cancer with polyICLC, and tremelimumab combined with systemic durvalumab
المؤلفون: Slingluff, Craig, Mauldin, Ileana, Gaughan, Elizabeth, Dillon, Patrick, Opyrchal, Mateusz, Puzanov, Igor, Kruse, Megan, Gastman, Brian, Friedlander, Philip, Marron, Thomas, Aufiero, Kristen, Macri, Mary, Schwarzenberger, Paul, Ricciardi, Toni, Ryan, Aileen, Venhaus, Ralph, Saxena, Mansi, Edmonds, Nicole, Bhardwaj, Nina
المصدر: Regular and Young Investigator Award Abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2021
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2021-sitc2021.337
DOI: 10.1136/jitc-2021-SITC2021.337
الإتاحة: https://doi.org/10.1136/jitc-2021-sitc2021.337Test
رقم الانضمام: edsbas.A6C23831
قاعدة البيانات: BASE